LANA -CF - Developing a novel long-acting subcutaneous peptide-based therapy for the treatment of Chronic Heart Failure
LANA-PL - Developing a novel long-acting aerosolized peptide-based therapy for the treatment of pulmonary diseases, including COPD, Asthma, and Pulmonary Hypertention
LASP - Developing a novel long-acting subcutaneous peptide-based therapy for the treatment of cardiovascular and metabolic diseases
LASC - Developing a novel long-acting subcutaneous peptide-based therapy for the treatment of cardiovascular diseases
Copyright © 2021 Antlia Bioscience, Inc. - All Rights Reserved.